FDA Licenses Simulations Plus's GastroPlus(TM)
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (AMEX:SLP), a leading provider of software for pharmaceutical discovery and development, today announced that it has received a purchase order from the U.S. Food and Drug Administration to license the Company’s GastroPlus™ simulation software.